Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 1378

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 1378
---
                                            of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and
                                            (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per
                                            share and exercisable for a term of 36 months from the date of issuance.
     
    The
    issuance was approved by the Company’s board of directors in February 2024.
     
    In
    the year ended December 31, 2024, the Company recorded $71, as stock-based equity awards with respect to the consultant. No expenses
    were recorded in the fiscal year ended December 31, 2023 with respect to the consultant.

    F-24

MY
SIZE, INC. AND ITS SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

U.S.
dollars in thousands (except share data and per share data)

NOTE
14 - STOCK BASED COMPENSATION (Cont.)

The
Company’s outstanding options granted to consultants as of December 31, 2024 are as follows:

SCHEDULE
OF OPTIONS GRANTED TO CONSULTANTS

    Issuance
    date 
    Options
    for Common stock  
    Weighted
    Average exercise price per share  
    Options
    exercisable  
    Expiration
    date

    September-October
    2020 
     112  
    USD
       216  
     112  
    September
    2025
  
    March
    2023 
     500  
    USD
    24  
     225  
    March
    2026

    Total 
     612  

     337  

The
Company uses the Black Scholes model to measure the fair value of the stock options with the assistance of a third party valuation.

The
fair value of the Company’s stock options granted to non-employees was calculated using the following weighted average assumptions:

SCHEDULE
OF FAIR VALUE ASSUMPTIONS OF STOCK OPTIONS

    2023 

    Grants 

    Dividend
    yield 
     - 
  
    Expected
    volatility 
     82.49%
  
    Risk-free
    interest 
     3.96%
  
    expected
    term of up to (years) 
     3 

    F-25

MY